7 Best Medical Technology Stocks To Buy According To Analysts
The MedTech sector is crucial in healthcare, which concentrates on the creation of medical devices aimed at enhancing disease prevention, diagnosis, and treatment.
Glaukos Corp (GKOS)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Citadel Investment Group Ken Griffin | 1,192,739 | $178,839,286 | +232% | 0.03% |
| 2. | Driehaus Capital Richard Driehaus | 820,123 | $122,969,243 | -5% | 1.01% |
| 3. | Millennium Management Israel Englander | 393,223 | $58,959,857 | +63% | 0.02% |
| 4. | Holocene Advisors Brandon Haley | 309,469 | $46,401,782 | 0.14% | |
| 5. | Braidwell LP Alex Karnal | 288,876 | $43,314,067 | -8% | 1.28% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $23.84 | 2,100 | 102,100 | 2017-11-22 | Filing | ||
| $16.03 | 2,500 | 5,000 | 2016-03-04 | Filing | ||
| $15.30 | 1,388 | 1,388 | 2015-12-31 | Filing | ||
| $15.30 | 1,388 | 4,656 | 2015-12-31 | Filing | ||
| $21.83 | 2,500 | 2,500 | 2015-11-12 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $108.14 | 31 | 53,431 | 2025-03-25 | Filing | ||
| $107.44 | 430 | 53,462 | 2025-03-25 | Filing | ||
| $106.56 | 1,059 | 53,892 | 2025-03-25 | Filing | ||
| $120.72 | 20,687 | 54,249 | 2025-02-26 | Filing | ||
| $147.14 | 3,416 | 72,437 | 2025-02-14 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 8,797,278 | $1,319,063,864 | 0.02% | |
| 2. | 6,111,756 | $916,396,741 | 0.05% | |
| 3. | 5,974,971 | $895,887,152 | 0.01% | |
| 4. | 2,159,539 | $323,801,278 | 0.05% | |
| 5. | 2,063,399 | $309,386,046 | 0.01% |
News See All
Glaukos Corporation (NYSE:GKOS) Q4 2024 Earnings Call Transcript
Operator: Welcome to Glaukos Corporation's Fourth Quarter and Full-Year 2024 Financial Results Conference Call.
Glaukos Corporation (NYSE:GKOS) Q3 2024 Earnings Call Transcript
Operator: Welcome to Glaukos Corporation's Third Quarter 2024 Financial Results Conference Call.
Here's Why Glaukos (GKOS) Appreciated in Q2
Brown Capital Management, an investment management company, released its “The Brown Capital Management Small Company Fund” second quarter 2024 investor letter.
Better Than Expected Earnings Results Boosted Glaukos Corp (GKOS) in Q2
Fred Alger Management, an investment management company, released its “Alger Weatherbie Specialized Growth Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here.
Should You Be Bullish on Glaukos Corporation (GKOS)?
Baron Funds, an investment management company, released its “Baron Health Care Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here.
Glaukos Corporation (NYSE:GKOS) Q2 2024 Earnings Call Transcript
Operator: Hello, and welcome to Glaukos Corporation's Second Quarter 2024 Financial Results Conference Call.
Glaukos Corporation (NYSE:GKOS) Q1 2024 Earnings Call Transcript
Operator: Welcome to Glaukos Corporation's First Quarter 2024 Financial Results Conference Call.
Glaukos Corporation (NYSE:GKOS) Q4 2023 Earnings Call Transcript
Glaukos Corporation misses on earnings expectations. Reported EPS is $-0.63 EPS, expectations were $-0.56.
Glaukos Corporation (NYSE:GKOS) Q3 2023 Earnings Call Transcript
Operator: Hello, and welcome to Glaukos Corporation's Third Quarter 2023 Financial Results Conference Call.